Nautilus Biotechnology’s Voyager platform uses single-molecule Iterative Mapping to quantify up to 10 billion intact proteins and proteoforms in one run.
Products & media
Meet the Nautilus Voyager Platform
Nautilus Voyager Platform
A benchtop single-molecule proteomics system designed to map and quantify billions of intact proteins and proteoforms.
Nautilus Proteomics Analysis Services
A fee-for-service early-access offering that runs customer projects with Nautilus' Iterative Mapping method before broad instrument availability.
Team
Founders
2 people
Jobs
See all jobs for Nautilus Biotechnology here.
Company history
All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.
Leads
Participating Firms
Angels
SPAC transaction
SPAC transaction completed · NASDAQ:NAUT